Ellen Scharaga of Melville, NY, a health care industry executive and Leukemia and Lymphoma Society (LLS) member, supports the mission of LLS to cure leukemia, lymphoma, and Hodgkin’s disease and to provide information and support to patients and their families. Ellen Scharaga shares LLS’ recent news on its Quest for Cures program.
Through Quest for Cures, the Leukemia and Lymphoma Society directs funds toward three areas of blood cancer research it has deemed critical for progressive treatment of patients. LLS is requesting research proposals in the areas of tumor cell clonal heterogeneity, molecular stratification mechanisms, and bone marrow and lymph node microenvironments.
The Quest for Cures project is operating in conjunction with Celgene, as part of LLS’ Targets, Leads, and Candidates initiative to select and fund critical research fields with backing from partners in the biotechnology and pharmaceutical industries.